Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression

Launched by HOSPITAL FOR SPECIAL SURGERY, NEW YORK · Sep 17, 2021

Keywords

ClinConnect Summary

This clinical trial is studying the use of steroids given during surgery to see how they affect recovery for patients undergoing a specific back surgery called lumbar laminectomy. The focus is on how these steroids might help reduce the need for pain medication after surgery, how long patients stay in the hospital, when they can return to work, and their overall satisfaction with the surgery results.

To be eligible for this trial, participants should be between the ages of 18 and 85 and scheduled for a 1 to 2 level laminectomy, which is a type of surgery to relieve pressure on the spinal nerves. However, those who have previously used strong pain medications daily, have certain health conditions, or are undergoing other types of surgeries at the same time may not qualify. Participants can expect to be monitored throughout their recovery to assess pain levels and overall health, contributing valuable information to help improve future treatments for back pain.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients scheduled to undergo 1 to 2 level laminectomy
• • Between the ages of 18-85
• Exclusion Criteria:
• • Minimally invasive surgery
• • Prior daily opioid usage within 6 months.
• • Use of concomitant procedures such as spinal fusion, revision procedure at the same level.
• • History of a chronic pain syndrome, uncontrolled diabetes defined as A1C \> 6.5, immunocompromised condition such as active cancer treatment, history of transplant, benign prostatic hyperplasia or history of urinary retention, and other conditions which require chronic steroid therapy or immunosuppressants.
• • Non-English speakers
• • Patients allergic to Depo-Medrol and/or glucocorticoids, or other steroids